Literature DB >> 27043731

Lesional perfusion abnormalities in Leigh disease demonstrated by arterial spin labeling correlate with disease activity.

Matthew T Whitehead1,2, Bonmyong Lee3, Andrea Gropman4,5.   

Abstract

BACKGROUND: Leigh disease is a metabolic disorder of the mitochondrial respiratory chain culminating in symmetrical necrotizing lesions in the deep gray nuclei or brainstem. Apart from classic gliotic/necrotic lesions, small-vessel proliferation is also characteristic on histopathology. We have observed lesional hyperperfusion on arterial spin-labeling (ASL) sequence in children with Leigh disease.
OBJECTIVE: In this cross-sectional analysis, we evaluated lesional ASL perfusion characteristics in children with Leigh syndrome.
MATERIALS AND METHODS: We searched the imaging database from an academic children's hospital for "arterial spin labeling, perfusion, necrosis, lactate, and Leigh" to build a cohort of children for retrospective analysis. We reviewed each child's medical record to confirm a diagnosis of Leigh disease, excluding exams with artifact, technical limitations, and without ASL images. We evaluated the degree and extent of cerebral blood flow and relationship to brain lesions. Images were compared to normal exams from an aged-matche cohort.
RESULTS: The database search yielded 45 exams; 30 were excluded. We evaluated 15 exams from 8 children with Leigh disease and 15 age-matched normal exams. In general, Leigh brain perfusion ranged from hyperintense (n=10) to hypointense (n=5). Necrotic lesions appeared hypointense/hypoperfused. Active lesions with associated restricted diffusion demonstrated hyperperfusion. ASL perfusion patterns differed significantly from those on age-matched normal studies (P=<.0001). Disease activity positively correlated with cerebral deep gray nuclei hyperperfusion (P=0.0037) and lesion grade (P=0.0256).
CONCLUSION: Children with Leigh disease have abnormal perfusion of brain lesions. Hyperperfusion can be found in active brain lesions, possibly associated with small-vessel proliferation characteristic of the disease.

Entities:  

Keywords:  Arterial spin labeling; Children; Leigh disease; Magnetic resonance imaging; Metabolic disease; Perfusion

Mesh:

Substances:

Year:  2016        PMID: 27043731     DOI: 10.1007/s00247-016-3616-9

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  28 in total

1.  Pediatric perfusion imaging using pulsed arterial spin labeling.

Authors:  Jiongjiong Wang; Daniel J Licht; Geon-Ho Jahng; Chia-Shang Liu; Joan T Rubin; John Haselgrove; Robert A Zimmerman; John A Detre
Journal:  J Magn Reson Imaging       Date:  2003-10       Impact factor: 4.813

2.  MR spectroscopy of the brain in Leigh syndrome.

Authors:  P E Sijens; G P A Smit; L A Rödiger; F J van Spronsen; M Oudkerk; R J Rodenburg; R J Lunsing
Journal:  Brain Dev       Date:  2008-03-10       Impact factor: 1.961

3.  Proton MR Spectroscopy in Patients with Leigh Syndrome.

Authors:  E Jurkiewicz; S Chełstowska; I Pakuła-Kościesza; K Malczyk; K Nowak; M Bekiesińska-Figatowska; J Sykut-Cegielska; D Piekutowska-Abramczuk; E Pronicka
Journal:  Neuroradiol J       Date:  2011-06-24

Review 4.  Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus.

Authors:  Amogh N Hegde; Suyash Mohan; Narayan Lath; C C Tchoyoson Lim
Journal:  Radiographics       Date:  2011 Jan-Feb       Impact factor: 5.333

Review 5.  Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 6.  Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

7.  99mTc-HMPAO brain single photon emission computerized tomography in mitochondrial encephalomyopathies.

Authors:  T C Yen; S H Yeh
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1995-11

8.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

9.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

Review 10.  The genetics of Leigh syndrome and its implications for clinical practice and risk management.

Authors:  Ilene S Ruhoy; Russell P Saneto
Journal:  Appl Clin Genet       Date:  2014-11-13
View more
  4 in total

1.  Do lesional perfusion abnormalities on arterial spin labeling truly contribute to the diagnosis of Leigh syndrome?

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Pediatr Radiol       Date:  2016-11-08

2.  Reply regarding lesional perfusion abnormalities on arterial spin labeling in Leigh disease.

Authors:  Matthew T Whitehead; Bonmyong Lee; Andrea Gropman
Journal:  Pediatr Radiol       Date:  2016-11-08

Review 3.  Magnetic resonance imaging of the brainstem in children, part 1: imaging techniques, embryology, anatomy and review of congenital conditions.

Authors:  Asha Sarma; Josh M Heck; Josephine Ndolo; Allen Newton; Sumit Pruthi
Journal:  Pediatr Radiol       Date:  2021-01-26

4.  Genetic and Mitochondrial Metabolic Analyses of an Atypical Form of Leigh Syndrome.

Authors:  Martine Uittenbogaard; Kuntal Sen; Matthew Whitehead; Christine A Brantner; Yue Wang; Lee-Jun Wong; Andrea Gropman; Anne Chiaramello
Journal:  Front Cell Dev Biol       Date:  2021-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.